Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 1, 2026

Enterprise Software Leaders Build AI Agents With NVIDIA

View original at finance.yahoo.com
Enterprise Software Leaders Build AI Agents With NVIDIA NVIDIA Enterprise Software Leaders Build AI Agents With NVIDIANVIDIA today announced new software, open source models and partnerships with the world’s leading software platform providers to build autonomous AI agents for industries and enterprises across engineer…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Autonomous AI agents require a software layer called a harness to turn a model into an agent with functions like orchestration, context, memory, tool use and security

    60% confidence
  • NVIDIA Nemotron 3 Ultra delivers up to 30% lower cost for complex agentic tasks

    60% confidence
  • Cadence, Dassault Systèmes, Siemens and Synopsys are using NVIDIA NemoClaw to build autonomous AI engineers that compress weeks of engineering work into hours

    60% confidence
  • NVIDIA Nemotron 3 Ultra delivers 5x faster inference for complex agentic tasks compared to prior models

    60% confidence
  • The world's software leaders are bringing AI agents into the systems where work gets done, showing how AI coworkers help employees think faster and execute complex tasks to solve bigger problems, and NVIDIA NemoClaw provides enterprise software developers with the open building blocks to create more secure long-running AI coworkers that amplify human expertise

    60% confidence
  • CrowdStrike and Palantir are transforming cybersecurity and operational decision-making with long-running AI agents powered by Nemotron open models, enabling teams to analyze data faster and streamline operations across complex environments

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Enterprise Software Leaders Build AI Agents With NVIDIA — Source | Via News | Via News